Ncardia, an drug discovery and stem cell technology company, has raised 10.5 million euros in Series B financing. Épimède led the round.
Source: Press Release
Ncardia, an drug discovery and stem cell technology company, has raised 10.5 million euros in Series B financing. Épimède led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: